Lonza to Make Trading Debut on the Singapore Exchange

This will ultimately reap benefits for our investors and deliver strong returns to our shareholders who now have access to the fastest growing part of the world.

Oct 20 2011 --- Lonza Group Ltd, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, expects to make its trading debut on the Main Board of the Singapore Exchange Securities Trading Limited (“SGX-ST”) at 9:00 am tomorrow, 21 October 2011 (Singapore time).

Listed on the SIX Swiss Exchange (the “SIX”) since November 1999, Lonza is the first SIX Swiss-listed company to be secondary listed by way of an introduction on the SGX-ST. Based on the closing market price of the company’s shares quoted on the SIX on 19 October 2011, Lonza has a market capitalization of approximately CHF 2,982 million. This corresponds to approximately SGD 4,183 million based on an exchange rate of CHF 1.00 to SGD 1.4028 as quoted by Bloomberg on 19 October 2011.

Mr Stefan Borgas, Chief Executive Officer of Lonza, reiterated the Group’s commitment to Asia, “This is an exciting and historic day for us, and marks an important milestone for Lonza. The successful listing on the SGX-ST will help enhance our corporate profile in the region and enable the Group to further tap into the market growth in Asia.”

“With a listing status both in Switzerland and Singapore, Lonza will enjoy a wide range of options to access capital and maximize our growth potential. We look towards broadening our investor base in Asia and creating a ‘local currency’ for future growth in the region. This will ultimately reap benefits for our investors and deliver strong returns to our shareholders who now have access to the fastest growing part of the world.”

UBS AG, Singapore Branch acted as the issue manager for the introduction and Drew and Napier LLC acted as the solicitors to the introduction and legal advisers to the company as to Singapore law.

Lonza will be secondary listed on the SGX-ST and will not be subject to the SGX-ST’s continuing listing requirements. Lonza is subject to the listing rules of the SIX, which do not have specific requirements equivalent to the listing rules of the SGX-ST in respect of interested person transactions, acquisition and realisations, and delisting.